Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-561-0 | CAS number: 9046-10-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity - oral: The oral LD50 in rats was determined to be 2885 mg/kg bw in a study conducted similarly to OECD guideline 401 (Mallory, 1993).
Acute toxicity - inhalation: No mortality occurred when rats were exposed to air near-saturated with the test substance vapor for 8 hours (Bio/dynamics Inc., 1979). the LC50 is considered to be > 0.74 mg/L.
Acute toxicity - dermal: In a study conducted similarly to OECD guideline 402, the acute dermal LD50 was determined to be 2980 mg/kg bw in New Zealand White rabbits (Mallory, 1993).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1992-02-05 - 1992-03-11
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Remarks:
- Limited information on the test substance.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Name as cited in study report: 6398-9-20
- Color: clear
- Storage: during storage no change in the physical state of test article
- Specific gravity: 0.948 g/mL - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Inc., Wilmington, Massachusetts, USA
- Age at study initiation: 6-10 weeks
- Weight at study initiation: 155-291 g (dose-range finder), 157-232 g (main test); weight variation in each sex did not exceed +/- 20%
- Fasting period before study: yes
- Housing: individually in stainless steel wire mesh cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 30-70 %
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 4.22 ml/kg bw (based on max. dose level 4000 mg/kg bw and specific gravity 948 mg/ml)
DOSAGE PREPARATION (if unusual): test article was dosed as received using specific gravity calculations. - Doses:
- 0 (water), 2000, 2500, 3000, 4000 mg/kg bw
- No. of animals per sex per dose:
- 5 substance exposed animals, 3 control animals
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations at 1h, 4h, 24h after dosing and once daily thereafter; body weights at 0h, 7d and 14d after exposure (or when found dead).
- Necropsy of survivors performed: yes
- Other examinations performed: toxicological effects, viability, gross necropsy, histopathology (of control and highest dose group) - Statistics:
- LD50 calculations according to Litchfield and Wilcoxon.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 885.3 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 2 400.7 - <= 3 467.7
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 922.1 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 2 308.9 - <= 3 698.2
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 627.2 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 2 157.7 - <= 3 198.8
- Mortality:
- No mortality in 6 control rats (3M/3F)
2000 mg/kg: 1/5 females
2500 mg/kg: 3/5 males and 2/5 females
3000 mg/kg: 1/5 males and 3/5 females
4000 mg/kg: 5/5 males and 5/5 females
All deads occurred on or 1 day after the day of exposure. - Clinical signs:
- other: Decreased activity during the first few days after exposure only (only for substance exposed rats). Dyspnea during the first few days after exposure only (in 2500-3000-4000 dosed rats)
- Gross pathology:
- In exposed animals that died during the study: distended stomach and intestines (all dose levels), dark or pale organs (3000 and 4000 mg/kg).
No visible lesions in control animals and all survivors. - Other findings:
- No treatment related findings compared to control rats.
- Interpretation of results:
- not classified
- Conclusions:
- In view of the LD50 value of 2885 mg/kg bw in this rat study, the substance does not need to be classified for acute oral toxicity according to the CLP Regulation (EC)1272/2008.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- No information on study design and methodology was presented.
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- no guideline followed
- GLP compliance:
- not specified
- Test type:
- other: Data not available
- Limit test:
- no
- Specific details on test material used for the study:
- No test item information provided
- Species:
- rat
- Strain:
- other: Albino (MR Wistar)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
-Mean weight at study initiation:
0.59 g/kg: 150
1.18 g/kg: 152
2.35 g/kg: 150
4.70 g/kg: 150
- Fasting period before study: animals fasted for 24 hours were dosed with the test substance as received - Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Details on oral exposure:
- animals fasted for 24 hours were dosed with the test substance as received
- Doses:
- 0.59, 1.18, 2.35, 4.70 g/kg
- No. of animals per sex per dose:
- 5 males/dose
- Control animals:
- no
- Details on study design:
- - Frequency of weighing: beginning and end of study
- Necropsy of survivors performed: yes - Statistics:
- no information provided
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 660 mg/kg bw
- Based on:
- not specified
- Remarks on result:
- other: mean
- Mortality:
- Mortality
0.59 g/kg: 0/5
1.18 g/kg: 2/5
2.35 g/kg: 3/5
4.70 g/kg: 5/5
Onset of death
1.18 g/kg: two deaths at 6-24 hours
2.35 g/kg: two dealth at 6-24 hours and 1 death at 2 days
4.70 g/kg: four deaths at 0-6 hours and 1 death at 6-24 hours - Gross pathology:
- Survivors - normal
- Other findings:
- No signs of intoxication were observed
- Interpretation of results:
- sligthly toxic
- Conclusions:
- The test substance is considered to be slightly toxic by ingestion in single doses.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 885 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1979-01-17 - 1979-05-03
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Remarks:
- However, limited details were provided on exposure conditions (i.e., particle size determination), test substance (i.e., purity), and animal husbandry. Only one concentration was used and exposure was for 8 hours without a justification provided.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- Limited details were provided on exposure conditions (i.e., particle size determination), test substance (i.e., purity), and animal husbandry. Only one concentration was used and exposure was for 8 hours without a justification provided.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Name as cited in study report: Poly[oxy(methyl-1,2-ethanediyl)], alpha-(2-aminomethylethyl)-omega-(2-aminomethylethoxy)
- Substance type: active
- Color: clear, amber
- Lot: Jefferson chemical company, sample no. AVS-0381, 4236-10-20a, SPC no. 1575 - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Wilmington, Massachusetts
- Weight at study initiation: 209-254
- Other: The animals were observed prior to exposure to assure that they were free from abnormalities.
IN-LIFE DATES: From: 1979-01-17 To: 1979-01-31 - Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Remarks:
- dry
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: A glass exposure chamber housed the animals.
- Exposure chamber volume: 26.5 liter
- Source and rate of air: 4.0 liters per minute
- Method of conditioning air: The test substance was placed in a 500 milliliter gas-washing bottle. Dry air, at the minimum chamber flow rate of 4.0 liters per minute, was passed through the test substance and the resultant vapor-laden air was directed, undiluted, into the exposure chamber housing the test animals.
- Temperature, humidity, pressure in air chamber: the chamber temperature during the exposure was 22 degrees C.
- Other: The flask containing the test substance, two glass tubes, and connectors were weighed before and after the exposure period. The difference in weight was equal to the amount of test substance volatilized during the exposure. The nominal concentration was calculated by dividing the weight loss by the total air flow through the chamber during the exposure period. - Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- ca. 8 h
- Concentrations:
- 0.74 mg/L (1.42 grams of test substance delivered in a total volume of 1920 liters of dry air)
- No. of animals per sex per dose:
- 5 animals per sex
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations for abnormal signs were recorded at 15 minute intervals for the first hour of exposure, hourly for the remaining seven hours of the exposure, upon removal from the chamber, at one hour post-exposure, and daily thereafter for 14 days. Individual body weights were recorded on day 0 (prior to exposure) and on Days 1, 2, 4, 7 and 14 (terminus) for all animals.
- Necropsy of survivors performed: yes; On Day 14 all animals were sacrificed (ethyl ether) and gross necropsy examinations were performed. - Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 0.74 mg/L air (nominal)
- Based on:
- test mat.
- Exp. duration:
- 8 h
- Remarks on result:
- other: No mortality was observed at 0.74 mg/L
- Mortality:
- No mortalities occurred.
- Clinical signs:
- other: No abnormalities were observed in any animals during the exposure. Upon removal from the chamber, one animal was observed to have dry rales. At one-hour post-exposure dry rales was noted again in the same animal. During the 14-day observation period dr
- Body weight:
- Individual body weight data showed normal weight gains in all animals except one male, which showed a somewhat depressed weight gain pattern.
- Gross pathology:
- Necropsy examinations revealed lung discoloration in nine of ten animals and kidney discoloration in six of ten animals. The frequency of lung and kidney discoloration was higher than that normally observed in Sprague-Dawley rats in this type of exposure and may have been indicative of a response to the exposure.
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The acute inhalation toxicity of the test substance was evaluated in male and female rats. The LC50 was determined to be >0.74 mg/L.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: No information on study design and methodology was presented.
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- no guideline available
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Limit test:
- no
- Specific details on test material used for the study:
- No test item information provided
- Species:
- rat
- Strain:
- other: albino (MR Wistar)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Mean weight at study initiation: 168 - Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- not specified
- Vehicle:
- air
- Details on inhalation exposure:
- Animals were exposed to air near-saturated with vapor of the test substance for 7 hours at 25 °C.
- Analytical verification of test atmosphere concentrations:
- not specified
- Duration of exposure:
- 7 h
- Concentrations:
- Animals were exposed to air near-saturated with vapor of the test substance.
- No. of animals per sex per dose:
- 10 animals/dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days (or other?) no data
- Frequency of observations and weighing: no data
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: limited data - Preliminary study:
- No animals died after receiving a 7 hr exposure to near-saturated vapor at 25 °C. 0/10 animals died. Discomfort, irritation, dyspnea were observed within 15 minutes. Moderate skin irritation was seen within 30 minutes followed by a decrease in motor activity. Rapid recovery following exposure. Gross autopsy was normal.
- Mortality:
- 0/10
- Clinical signs:
- other: Discomfort, irritation, dyspnea within 15 minutes. Moderate skin irritation within 30 minutes followed by decrease in motor activity. Rapid recovery following exposure.
- Body weight:
- Mean body weight at termination 310
- Gross pathology:
- Normal
- Interpretation of results:
- relatively harmless
- Conclusions:
- The rats exhibited discomfort, irritation, dyspnea within 15 minutes of inhalation exposure to the test substance. Moderate skin irritation was present within 30 minutes, followed by a decrease in motor activity. Rapid recovery following exposure.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 740 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1992-04-22 to 1992-07-09
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Remarks:
- Limited information on the test substance available.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Name as cited in study report: 6398-9-20
- Lot/Batch number: 6398-9-20
- Color: clear
- Storage: during storage no change in physical state of the test article
- specific gravity: 0.948 g/ml - Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hazleton Research Products, Denver, PA, USA
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 2233 - 3574 g
- Fasting period before study: no, not applicable
- Housing: individually in cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 +/- 3°C
- Humidity (%): 30-70%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: no data
- % coverage: at least 10% of the body surface was cleared
- Type of wrap if used: rubber dam and an elastic bandage
REMOVAL OF TEST SUBSTANCE
- Washing (if done): with water
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): control: 5.6-7.3 ml water; 500 mg/kg dose: 1.3-1.9 ml test substance; 2000 mg/kg dose: 5.4-7.5 ml; 3200 mg/kg dose: 9.7-11.4 ml; 4000 mg/kg dose: 9.4-12.2 ml.
- Constant volume or concentration used: no - Duration of exposure:
- 24 hours
- Doses:
- 0 (water), 500, 2000, 3200, 4000 mg/kg bw
- No. of animals per sex per dose:
- 5 in substance-treated groups and 3 in controls.
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations once daily; body weights at 0h, 7d and 14d after exposure (or when found dead).
- Necropsy of survivors performed: yes
- Other examinations performed: toxicological effects, viability, gross necropsy, histopathology (of control and highest dose group) - Statistics:
- Method of Litchfield & Wilcoxon.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 979.7 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 993.8 - <= 8 934.1
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 979.7 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 2 037.4 - <= 4 357.9
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 979.7 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 2 037.4 - <= 4 357.9
- Mortality:
- Control: no mortality
500 mg/kg: no mortality
2000 mg/kg: no mortality
3200 mg/kg: 4/5 females and 4/5 males died during the first 3 days
4000 mg/kg: all animals died within 2 days. - Clinical signs:
- other: Decreased activity, abnormal gait, abnormal stance, dyspnea, body drop, prostration in 2000-3200-4000 mg/kg dose animals. No clinical signs in control animals and in 500 mg/kg dose animals. Necrosis of the skin at the application site was observed in all
- Gross pathology:
- Animals that died during the study: discolored thymus and liver, prominent lobular pattern throughout the liver.
Survivors: no relevant effects. - Other findings:
- Histopathology: no treatment related effects.
- Interpretation of results:
- not classified
- Conclusions:
- In view of the LD50 value of 2980 mg/kg bw in this rabbit study, the substance does not need to be classified for acute dermal toxicity according to the CLP Regulation (EC) 1272/2008.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: No information on study design and methodology was presented.
- Qualifier:
- no guideline available
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- No test item information provided
- Species:
- rabbit
- Strain:
- other: albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
-Mean weight at study initiation:
DOSE: Weight (g)
0.29 g/kg: 3.25
0.59 g/kg: 3.00
1.18 g/kg: 2.84
2.35 g/kg: 2.89 - Type of coverage:
- occlusive
- Vehicle:
- not specified
- Details on dermal exposure:
- TEST SITE
- Type of wrap if used: impervious cuff
TEST MATERIAL
- Concentration (if solution):
0.29 g/kg
0.59 g/kg
1.18 g/kg
2.35 g/kg - Duration of exposure:
- 24 hours - continuous
- Doses:
- 0.29, 0.59, 1.18, 2.35 g/kg
- No. of animals per sex per dose:
- 5 animals/dose
- Control animals:
- not specified
- Details on study design:
- - Frequency of weighing: at beginning and end of study
- Statistics:
- no information was provided
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 760 other: mg/kg
- Based on:
- not specified
- Remarks on result:
- other: mean
- Mortality:
- Mortality
0.29 g/kg: 1/5
0.59 g/kg: 0/5
1.18 g/kg: 5/5
2.35 g/kg: 5/5
Onset of death
0.29 g/kg: one death at 6-24 hours
0.59 g/kg: N./A
1.18 g/kg: five deaths at 6-24 hours
2.35 g/kg: five deaths at 6-24 hours - Clinical signs:
- other: Signs of intoxication: Diarrhea, exudate around mouth and nose, hind leg weakness. Onset of signs 0.29 g/kg: 1 death at 6-24 hours 0.59 g/kg: N/A 1.18 g/kg: five animals at 6-24 hours with signs/death 2.35 g/kg: five animals at 6-24 hours with signs/deat
- Gross pathology:
- animals at 0.59 g/kg dose appeared normal
- Other findings:
- Signs of intoxication: Diarrhea, exudate around mouth and nose, hind leg weakness.
- Interpretation of results:
- other: corrosive
- Conclusions:
- The test substance is corrosive to the skin of the rabbit. Therefore, precautions should be observed to prevent skin contact with the product.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 980 mg/kg bw
Additional information
Acute toxicity studies of sufficient quality and conducted in methods comparable to OECD guidelines were available for oral, dermal, and inhalation routes of exposure to the test substance.
Acute toxicity: oral
The acute oral study was conducted using methods comparable to OECD guideline 401 (Mallory, 1993). Groups of 5 male and 5 female rats received an oral dose of test substance by gavage at 2000, 2500, 3000 and 4000 mg/kg bw, and the acute oral LD50 was determined to be 2885 mg/kg bw (combined sexes). Lower LD50 values were found in other studies which were assigned either not reliable (Klimisch 3) or not assignable (Klimisch 4). In these older studies, the used methods were poorly described. Furthermore, no constant dosing volume was applied, which could be the cause of the higher mortality.
Acute toxicity: dermal
In the acute dermal study conducted using methods similar to OECD guideline 402, groups of 5 male and 5 female New Zealand White rabbits were exposed to the test substance for 24 hours occlusively at 500, 2000, 3200 and 4000 mg/kg bw (Mallory, 1993). The acute dermal LD50 was determined to be 2980 mg/kg bw (combined sexes). Lower LD50 values were found in other studies which were assigned either not reliable (Klimisch 3) or not assignable (Klimisch 4). In these older studies, the used methods were poorly described. Furthermore, no constant dosing volume was applied, which could be the cause of the higher mortality.
Acute toxicity: inhalation
In the acute inhalation study conducted using methods similar to OECD guideline 403, groups of rats were exposed to air nearly saturated with the test substance vapor for 8 hours (Bio/dynamics Inc., 1979). The nominal concentration was calculated to be 0.74 mg/L (740 mg/m3). No mortality occurred during the 14 day observation period. LC50 was considered thus > 0.74 mg/L.
Justification for classification or non-classification
The oral LD50 of 2885 mg/kg falls outside the hazard categories for acute oral toxicity, and therefore no classification is warranted for the oral route.
The dermal LD50 of 2980 mg/kg falls outside the hazard categories for acute dermal toxicity, and therefore no classification is warranted for the dermal route.
The inhalatory LC50 is set at greater than 740 mg/m³, as it is based on one dose tested only. Therefore, no conclusion can be made on the classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.